Insurance startup Oscar Health plans to price its IPO between $32 and $34 per share. The New York-based startup plans to trade on the New York Stock Exchange under the ticker “OSCR.”
Digital health startup Sharecare plans to go public through a merger with a blank-check company created by Alan Mnuchin. The deal will value the company at $3.9 billion.
What You Should Know: – Digital health company Sharecare and special purpose acquisition company (SPAC), Falcon Capital Acquisition Corp, today announced an agreement to merge to go public on the NASDAQ under the ticker symbol SHCR at enterprise value of $3.9B. – The transaction is… Read More »Sharecare to Go Public in SPAC IPO Deal, Reaching $3.9B Valuation
Signify Health, a company that provides services for value-based care programs, went public on Thursday in an upsized IPO. The company’s stock began trading at $24 per share, above its expected range of $20 to $21 per share.
What You Should Know: – Shares of Signify Health, a value-based care billing platform for in-home and bundled health services jumped more than 33% in its initial public offering (IPO), valuing the company at over $7.12B. – Today, Signify Health’s CEO Kyle Armbrester will also… Read More »Signify Health Shares Soar More Than 33% in IPO, Valuing Company at Over $7.12B
Consumer DNA testing company 23andMe plans to go public through a merger with a special-purpose acquisition company started by Virgin Group. As sales of DNA testing kits wane, how will 23andMe drum up new interest for its business?
Walgreens appoints Rosalind (Roz) Brewer as the company’s Chief Executive Officer, effective on March 15, 2021. Brewer will also join the WBA Board of Directors upon assuming the role. She succeeds Stefano Pessina who, as previously announced, will transition to the role of Executive Chairman… Read More »Executive Hires: Walgreens Appoints New CEO, Cityblock Health, Innovaccer, Others
Compute Health Acquisition Corp Chairman Omar Ishrak What You Should Know: – Compute Health Acquisition, a SPAC company targeting the intersection of computation and healthcare announced the pricing of its $750M initial public offering (IPO) by offering 75 million units at $10. Compute Health Acquisition… Read More »SPAC Compute Health Acquisition Prices $750M IPO, Led by Intel Chairman
Sana Biotechnology is turning new science into novel medicines intended to overcome limitations of current cell therapies. After going from stealth to IPO in two years, it’s now planning to bring multiple programs into clinical testing in 2022.
What You Should Know: – Casana raises $14M in Series A funding to pursue FDA clearance for its an IoT heart health toilet seat that captures clinically relevant measurements, including heart rate, blood pressure, blood oxygenation, and cardiac output. Casana, previously known as Heart Health… Read More »Casana Raises $14M to Expand IoT Heart Health Toilet Seat
New figures have confirmed that the UK’s biotech sector received a massive boost from the COVID-19 pandemic last year, with investment levels soaring to £2.8 billion ($3.8 billion) from a level of £1.3 billion in 2019. That makes 2020 a new record year for the… Read More »UK biotech investment at record levels amid COVID-19
Direct-to-consumer health startup Ro is reportedly in talks go public through a merger with a blank-check company, according to a report by Reuters.
Sharecare, a digital health startup created by Web MD founder Jeff Arnold and Dr. Mehmet Oz, is reportedly in talks to go public through a merger with a special-purpose acquisition company. It also recently acquired startup Doc.ai.
The three-year-old digital health startup began trading on the New York Stock Exchange on Thursday. It merged with a subsidiary of Oaktree Capital Management in a deal that valued the company at $1.6 billion.
Signify Health, a startup that provides in-home healthcare services and value=based payment programs, filed early paperwork for an IPO. The company plans to be traded on the New York Stock Exchange under the ticker “SGFY.”
The digital therapy provider plans to go public through a blank-check acquisition by Hudson Executive Capital. The deal would value Talkspace at $1.4 billion and provide $250 million in capital.
On the heels of a $140 million funding round, insurance startup Oscar Health confidentially filed for an IPO.
AbCellera Biologics has been in the spotlight since coming up with Eli Lilly’s COVID-19 antibody drug bamlanivimab, and looks set to capitalise on that exposure with a sizeable initial public offering. The Vancouver, Canada-headquartered biotech – which has been bankrolled in part by billionaire entrepreneur… Read More »AI drug discovery biotech AbCellera eyes record IPO
What You Should Know: – Israeli-based G Medical Innovation has withdrawn its plans for an initial public offering (IPO) on Tuesday, Nasdaq first reports. – The company originally filed an IPO to raise $30 million by offering 5 million shares at a price range of… Read More »Israeli Digital Health Startup G Medical Innovations Withdraws $30M US IPO
By JESSICA DaMASSA, WTF HEALTH When Accolade went public in July at a $1.2B valuation, the BIG question facing the health tech unicorn pre-dated the covid-19 pandemic and the chaos facing its clientbase of large, self-insured employers: Could they scale? Raj Singh, Accolade’s CEO, tackles… Read More »Accolade’s CEO Raj Singh: IPO Backstory & Pop Health Predictions for 2021
The company, which offers a remote scribe services, secured $25 million in private placement financing and began trading publicly on the OTC markets after a reverse merger with Malo Holdings.
When it announced plans to go public through a blank-check company, Clover Health shared ambitious projections for its future membership. Much of that growth is pinned on plans to launch a direct contracting business.
Today on Health in 2 Point 00, Jess and I gossip about the wild rumor that UnitedHealthcare is acquiring Amwell. On Episode 157, we discuss Lark raising $55 million in a Series C along with a deal with Anthem to be their preferred DPP provider,… Read More »#Healthin2Point00, Episode 157 | The phrase is “Takeout Speculation”!
The direct-to-consumer telehealth startup will go public through a merger with special purpose acquisition company Oaktree Acquisition Corp. The combined entity is expected to be valued at $1.6 billion.
GoodRx, a digital health startup that helps users track prescription drug prices, filed for an IPO on Friday. The company hasn’t yet priced its shares, but plans to be listed on Nasdaq as “GDRX.”
Amwell filed preliminary paperwork for an IPO. The telehealth company also struck a partnership with Google, which will buy $100 million of its class C common stock.
Outset Medical, a San Jose-based company making portable dialysis machines, filed the initial paperwork for an IPO. The company has not yet set a price range for its stock, but said it plans to raise roughly $100 million.
– Healthcare Growth Partners’ (HGP) summary of Health IT/digital health mergers & acquisition (M&A) activity, and public company performance during the month of July 2020. While a pandemic ravages the country, technology valuations are soaring. The Nasdaq hit an all-time high during the month of… Read More »Analysis: July Health IT M&A Activity; Public Company Performance
What You Should Know: – Siemens Healthineers and Varian Medical announce a $16.4B deal in an all-cash transaction on 2nd August 2020. – Deal expected to close in 1H 2021. – Varian Medical will maintain its brand name and operate “independently” – Siemens AG will… Read More »M&A Analysis: 3 Benefits of Siemens Healthineers’ $16.4B Acquisition of Varian Medical
Oak Street Health, which operates primary care centers for Medicare patients, went public on Thursday for $328 million. Its capitation payment model has helped the company continue on where many clinics have struggled during the Covid-19 pandemic.
GoodRx, a startup that makes tools for comparing the price of prescription drugs, is looking to go public, according to a report by Reuters. The company reportedly submitted paperwork to the Securities and Exchange Commission.
US biotech Inozyme Pharma is the latest to jump on to the IPO bandwagon, setting terms for a $75 million stock market launch, as the firm gears up for clinical trials of its lead drug for rare bone diseases. Based in Boston, Massachusetts, the company… Read More »Inozyme plans $75m IPO as it heads for clinic with rare bone diseases drug
Healthcare Growth Partners, an Investment Banking and Strategic Advisory firm exclusively focused on the transformational health IT market, today announced the release of its Semi-Annual Health IT Market Review report that summarizes M&A and private equity activity across health IT, health information services, and digital health.… Read More »HGP Semi-Annual Health IT Market Review: 6 Key Trends to Know
GoHealth, an online insurance broker focusing on Medicare Advantage plans, went public on Wednesday for $914 million. The company will trade on Nasdaq under the ticker “GOCO.”
Oak Street Health, a Chicago-based company that operates primary care centers for Medicare patients, filed initial IPO paperwork on Friday. The company has not yet priced the offering, but it plans to use the proceeds to repay a loan and grow its business.
Today on Health in 2 Point 00, Jess and I cover some big news! Accolade has filed its IPO, so on Episode 132 I give my take on this health care navigation service. We also cover Somatus getting $64 million for chronic kidney disease care,… Read More »